ALEXANDRIA JOHNSON: Open Payments
NPI 1114351202 · SALEM, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 85 payments from 14 companies in 2025. Trend: 2023 $926 · 2024 $1,433 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $462 |
| AstraZeneca Pharmaceuticals LP | 4 | $166 |
| Amgen Inc. | 13 | $143 |
| Exact Sciences Corporation | 6 | $98 |
| Novo Nordisk Inc | 5 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| SHIELD THERAPEUTICS INC | 1 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
Products named: VRAYLAR, AIRSUPRA, OTEZLA, UBRELVY, CAPLYTA, Cologuard Collection Kit, Kerendia, Rybelsus.
Industry payments across WV — which companies pay providers there.
